60 year mark reached in long-term radiation study

NewsGuard 100/100 Score

For the past 60 years, the National Academies have studied the health effects of radiation exposure in Japanese survivors of the atomic bombs dropped on Hiroshima and Nagasaki, Japan.

First known as the Atomic Bomb Casualty Commission (ABCC), the study group was reorganized in 1975 to form the Radiation Effects Research Foundation (RERF), which is now a cooperative Japan-U.S. research organization. To commemorate the many contributions of former and current ABCC/RERF employees and bomb survivors, the National Academy of Sciences is hosting a symposium, "Sixty Years of ABCC/RERF: Major Contributions and Future Studies."

Comments from the first director of ABCC, a Japanese survivor, and National Academy of Sciences President Ralph Cicerone will kick off the symposium, which will also include a panel discussion by five scientists who worked at the commission during its first 10 years. Former ABCC/RERF employees from Japan and the United States are also scheduled to attend.

Dr. Joe Gray, associate laboratory director for life and environmental sciences at the Lawrence Berkeley National Laboratory, will give the keynote address on the "Omic Revolution and Epidemiology." Additional sessions will look at the ABCC/RERF and its major scientific contributions, including findings and radiation risk assessments that have helped set the basis for the world's radiation protective standards. These include radiation risk estimates for cancer and other human diseases, an assessment of genetic effects in the first generation children of atomic bomb survivors, and radiation biology information of benefit to the survivors and their children.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Expanding research and clinical options for children with cancer